HRZN

Business Context and Reporting Period

Company: Horizon Technology Finance Corp (HRZN)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2019
Business Overview: An externally managed, closed-end, non-diversified business development company (BDC) and regulated investment company (RIC). The company primarily makes secured debt investments (venture loans) to development-stage companies in technology, life science, healthcare information and services, and cleantech industries.

Key Financial Metrics

Material Changes vs. Prior Period

• Investment Income Growth: Total investment income increased 15.8% year-over-year, driven by a 11.1% increase in the average size of the debt investment portfolio and higher LIBOR rates.
• Expense Fluctuations: Net expenses increased 27.9% to $5.1 million. This increase was partially offset by a $1.1 million waiver of performance-based incentive fees by the Advisor. Without the waiver, net expenses would have been significantly higher.
• Capital Raise: The company completed a follow-on public offering of 2.0 million shares in March 2019, raising net proceeds of $23.2 million.
• Portfolio Expansion: New debt investments totaled $38.1 million in Q1 2019 compared to $8.6 million in Q1 2018. Total portfolio fair value increased to $266.2 million from $248.4 million at year-end 2018.
• Realized Gains: The company reported a net realized gain of $1.2 million, a reversal from the $0.1 million loss in the prior year, primarily due to the sale of an equity investment and warrant terminations.

Guidance, Outlook, and Risks

• Advisor Fee Waiver: The Advisor irrevocably waived $1.1 million of performance-based incentive fees for the full year 2019. This waiver is not subject to recoupment and directly improved net investment income for the quarter.
• Liquidity and Leverage: The company maintains a 150% asset coverage ratio (approved by stockholders in October 2018), allowing for increased leverage. As of March 31, 2019, asset coverage was 218%. The company has $29.5 million of unused commitment capacity under its Key Facility.
• Stock Repurchase Program: The Board extended a program to repurchase up to $5.0 million of common stock at prices below NAV. No repurchases were made in Q1 2019.
• Joint Venture Activity: The company continues to co-invest through Horizon Secured Loan Fund I (HSLFI). HSLFI had total assets of $30.9 million as of March 31, 2019.
• Risks: Key risks include interest rate volatility (99% of debt portfolio is floating rate), the ability of portfolio companies to service debt, and the need to maintain RIC status to avoid corporate-level taxation.

Investor Verification Checklist

• Fee Waiver Sustainability: Verify if the $1.1 million incentive fee waiver is a one-time event or indicative of future fee structures, as it significantly impacts net investment income.
• Portfolio Concentration: Review the top five debt investments, which represented 30% of the total debt portfolio at cost, to assess concentration risk.
• Unrealized Depreciation: Investigate the $1.4 million in net unrealized depreciation, primarily attributed to one "other investment," to understand the specific credit or valuation drivers.
• Capital Deployment: Monitor the deployment of the $23.2 million raised in the March 2019 offering and the $15.0 million loan funded to Encore Dermatology, Inc. in April 2019.
• Asset Coverage Ratio: Confirm the company remains compliant with the 150% asset coverage requirement under the 1940 Act as leverage increases.